three-year data showst
Continue reading...
Sarepta’s Duchenne gene therapy slows disease progression, three-year data shows
Sarepta's Duchenne gene therapy slows disease progression, three-year data shows
Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit...
